guest ::
| Home > In process > Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease. > print |
| Home > In process > Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease. > print |
| 001 | 284043 | ||
| 005 | 20260120144235.0 | ||
| 024 | 7 | _ | |a 10.1002/alz.71103 |2 doi |
| 024 | 7 | _ | |a pmid:41549404 |2 pmid |
| 024 | 7 | _ | |a 1552-5260 |2 ISSN |
| 024 | 7 | _ | |a 1552-5279 |2 ISSN |
| 037 | _ | _ | |a DZNE-2026-00078 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kennedy, James T |b 0 |
| 245 | _ | _ | |a Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease. |
| 260 | _ | _ | |a Hoboken, NJ |c 2026 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1768916407_9456 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a It is unknown if neurodegeneration trajectories differ between Down syndrome (DS) and autosomal dominant Alzheimer's disease (ADAD), both of which are genetic forms of Alzheimer's disease (AD).We compared brain volumes in DS, ADAD, and unaffected family members serving as controls. Participants underwent magnetic resonance imaging (MRI) and amyloid positron emission tomography (PET), deriving volumetric and amyloid burden, respectively. Nonlinear associations between regional volumes and estimated years to clinical symptom onset (EYO) were evaluated using generalized additive mixed-models.Longitudinal data from 267 controls, 341 participants with DS, and 358 participants with ADAD were included, totaling 1908 scans. DS volumes were lower than ADAD and controls initially and dropped linearly. ADAD had similar volumes to controls until diverging, beginning at EYO -7. Amyloid was negatively associated with volume, with similar slopes in DS and ADAD.ADAD and DS demonstrate distinct patterns of brain volume decline prior to symptom onset despite being similarly affected by amyloid. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a MRI |2 Other |
| 650 | _ | 7 | |a amyloid |2 Other |
| 650 | _ | 7 | |a volume |2 Other |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Down Syndrome: pathology |2 MeSH |
| 650 | _ | 2 | |a Down Syndrome: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: pathology |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Brain: pathology |2 MeSH |
| 650 | _ | 2 | |a Brain: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Magnetic Resonance Imaging |2 MeSH |
| 650 | _ | 2 | |a Positron-Emission Tomography |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Longitudinal Studies |2 MeSH |
| 650 | _ | 2 | |a Organ Size |2 MeSH |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Disease Progression |2 MeSH |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 693 | _ | _ | |0 EXP:(DE-2719)DIAN-20090101 |5 EXP:(DE-2719)DIAN-20090101 |e Longitudinal Study on Dominantly Inherited Alzheimer's Disease |x 0 |
| 700 | 1 | _ | |a Wisch, Julie K |b 1 |
| 700 | 1 | _ | |a Boerwinkle, Anna H |b 2 |
| 700 | 1 | _ | |a Millar, Peter R |b 3 |
| 700 | 1 | _ | |a McKay, Nicole S |b 4 |
| 700 | 1 | _ | |a Brickman, Adam M |b 5 |
| 700 | 1 | _ | |a Chhatwal, Jasmeer P |b 6 |
| 700 | 1 | _ | |a Mendez, Patricio Chrem |b 7 |
| 700 | 1 | _ | |a Christian, Bradley T |b 8 |
| 700 | 1 | _ | |a Cohen, Anne |b 9 |
| 700 | 1 | _ | |a Cruchaga, Carlos |b 10 |
| 700 | 1 | _ | |a Daniels, Alisha |b 11 |
| 700 | 1 | _ | |a Flores, Shaney |b 12 |
| 700 | 1 | _ | |a Handen, Benjamin L |b 13 |
| 700 | 1 | _ | |a Hartley, Sigan L |b 14 |
| 700 | 1 | _ | |a Head, Elizabeth |b 15 |
| 700 | 1 | _ | |a Ibanez, Laura |b 16 |
| 700 | 1 | _ | |a Krisnsky-McHale, Sharon J |b 17 |
| 700 | 1 | _ | |a la Fougere, Christian |b 18 |
| 700 | 1 | _ | |a Lai, Florence |b 19 |
| 700 | 1 | _ | |a Laymon, Charles M |b 20 |
| 700 | 1 | _ | |a Lee, Joseph H |b 21 |
| 700 | 1 | _ | |a Lee, Jae-Hong |0 P:(DE-HGF)0 |b 22 |
| 700 | 1 | _ | |a Levin, Johannes |0 P:(DE-2719)2811659 |b 23 |u dzne |
| 700 | 1 | _ | |a Llibre-Guerra, Jorge |b 24 |
| 700 | 1 | _ | |a Aguillon, David F |b 25 |
| 700 | 1 | _ | |a Lott, Ira T |b 26 |
| 700 | 1 | _ | |a Mapstone, Mark |b 27 |
| 700 | 1 | _ | |a McDade, Eric |b 28 |
| 700 | 1 | _ | |a Morris, John |b 29 |
| 700 | 1 | _ | |a O'Bryant, Sid E |b 30 |
| 700 | 1 | _ | |a Price, Julie C |b 31 |
| 700 | 1 | _ | |a Rafii, Michael S |b 32 |
| 700 | 1 | _ | |a Roh, Jee Hoon |b 33 |
| 700 | 1 | _ | |a Rosas, H Diana |b 34 |
| 700 | 1 | _ | |a Schupf, Nicole |b 35 |
| 700 | 1 | _ | |a Supnet-Bell, Charlene |b 36 |
| 700 | 1 | _ | |a Xiong, Chengjie |b 37 |
| 700 | 1 | _ | |a Zaman, Shahid |b 38 |
| 700 | 1 | _ | |a Benzinger, Tammie L S |b 39 |
| 700 | 1 | _ | |a Gordon, Brian A |b 40 |
| 700 | 1 | _ | |a Ances, Beau M |b 41 |
| 700 | 1 | _ | |a Alzheimer's Brain Consortium - Down Syndrome |b 42 |
| 700 | 1 | _ | |a Network, the Dominantly Inherited Alzheimer's |b 43 |e Collaboration Author |
| 773 | _ | _ | |a 10.1002/alz.71103 |g Vol. 22, no. 1, p. e71103 |0 PERI:(DE-600)2201940-6 |n 1 |p e71103 |t Alzheimer's and dementia |v 22 |y 2026 |x 1552-5260 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/284043/files/DZNE-2026-00078.pdf |y Restricted |
| 856 | 4 | _ | |u https://pub.dzne.de/record/284043/files/DZNE-2026-00078.pdf?subformat=pdfa |x pdfa |y Restricted |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 23 |6 P:(DE-2719)2811659 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2025-01-06 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ALZHEIMERS DEMENT : 2022 |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2025-01-06 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-06 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ALZHEIMERS DEMENT : 2022 |d 2025-01-06 |
| 920 | 1 | _ | |0 I:(DE-2719)1111015 |k Clinical Research (Munich) |l Clinical Research (Munich) |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1111016 |k AG Levin |l Clinical Neurodegeneration |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a EDITORS |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a I:(DE-2719)1111015 |
| 980 | _ | _ | |a I:(DE-2719)1111016 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|